Cancer

LIMA1-Alpha Protein Predicts Head and Neck Cancer Patients who Can Be Cured with Surgery Alone

Researchers have developed an LIMA1-alpha assay that can identify head and neck cancer patients who can be cured with surgery alone.

Cancer

Gut Zoomer Gets Upgrade, Adds Microbial and Metabolic Insights

Vibrant Wellness has enhanced its Gut Zoomer microbiome panel with expanded microbial and metabolite testing.

Cancer

AI ‘Fragle’ Method Makes Cancer Tracking More Efficient

Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.

Colorectal Cancer Screening: Are Smartphones the Answer?

Jun 5, 2025 | Colorectal

A study found that colorectal cancer screening could be boosted by using a rapid, accurate app-read smartphone FIT.

Gastric Cancer Biomarkers Identified in New Study

Jun 5, 2025 | Unknown Origin & Other Cancer Types

A new research study identifies lncRNAs CBR3-AS1 and PCA3 as significantly overexpressed in gastric cancer tissues.

Partnership to Develop Companion Diagnostic Kit for Lymphoma

Jun 4, 2025 | Lymphoma

Foresight Diagnostics and QIAGEN have entered a global partnership to develop and commercialize a companion diagnostic kit for lymphoma.

Shield MCD Test Gets Breakthrough Device Designation

Jun 4, 2025 | Cancer

Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.

PREDICT DNA and SCANDARE Study Results Unveiled

Jun 3, 2025 | Breast

Personalis, Inc. unveiled promising new clinical data from the PREDICT DNA and SCANDARE studies at ASCO 2025.

ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening

Jun 2, 2025 | Colorectal

New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening.

Labcorp Expands Oncology Portfolio

May 30, 2025 | Cancer

Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.

MRD Detection Gets New Standard with Pathlight

May 29, 2025 | Breast

SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.

Breast Cancer Index Test Data Reinforces Efficacy

May 28, 2025 | Breast

Hologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.

Independent Validation of CLARITY MRD Assay Presented

May 22, 2025 | Lymphoma

Foresight Diagnostics announced the independent validation of its CLARITY MRD assay, showing strong prognostic performance.

Partnership to Accelerate Development of Ovarian Cancer Test

May 22, 2025 | Unknown Origin & Other Cancer Types

A strategic partnership has formed to accelerate the development a test for early ovarian cancer diagnosis using AI-powered analytics.

AI Blood Test Could Be Key to Measure Pancreatic Cancer Therapy Success

May 21, 2025 | Pancreatic

Researchers developed an AI-driven blood test, ARTEMIS-DELFI, that detects pancreatic cancer treatment response faster and more accurately.

Roche Receives FDA Nod for Lung Cancer Companion Diagnostic

May 20, 2025 | Lung Cancer

The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.

Study IDs Two New Breast Cancer Genes in Black Women

May 15, 2025 | Breast

A groundbreaking genetic study identified two novel breast cancer-linked genetic variants in Black South African women.

Oncologists: More Advanced Cancers, Current Tests Not Catching Cancer Recurrence Early Enough

May 13, 2025 | Cancer

Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.

Category: Cancer

Cancer

Cancer

Cancer